Showing results (601-610 of 1,995) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|April 23, 2011
Stroke and the immune system: from pathophysiology to new therapeutic strategiesRichard Macrez, Carine Ali, Olivier Toutirais, et al.The Lancet. Neurology|January 9, 2015
Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline dataKathrin Reetz, Imis Dogan, Ana S Costa, et al.The Lancet. Neurology|December 16, 2014
Wilson's disease and other neurological copper disordersOliver Bandmann, Karl Heinz Weiss, Stephen G KalerThe Lancet. Neurology|December 16, 2014
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trialWerner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, et al.The Lancet. Neurology|October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b studyMarcelo E Bigal, David W Dodick, Alan M Rapoport, et al.The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational researchReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targetsReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.The Lancet. Neurology|September 18, 2015
New therapeutic approaches for the prevention and treatment of migraineHans-Christoph Diener, Andrew Charles, Peter J Goadsby, et al.The Lancet. Neurology|October 27, 2015
Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expressionJohn N Constantino, Tony CharmanPageof 200